Yeh, no point selling now imo, not only will March push some of...

First 7 Last

Share
Profile

Follow
Fishinnick

9,288 Posts.

88

18/12/17

11:15

Post #: 29702891
Share

Originally posted by mo72 ↑

Morning all!!

A very interesting Christmas present to all of us who have been holding this for a long time! The timing is what interests me - Oracle have made a very clever play for ACX leading in to the holiday period in the hope that they at least get a jump on their competitors.

A 1% break fee if they do not get ACX is a rounding error but will cover their bid costs if they get out-bid by one of the other big boys. Will be fascinating to see where this trades at 11am as there is a good chance it will be above the $7.80 - why - because this is an absolute bargain for Oracle and because, I hope, their competitors will see that. I don't blame management at all. They have locked in a base price at a 47% premium in a market where the analysts have never understood the value of ACX and there was a good chance they never would. Also, if they knocked this back convincingly there is also a good chance Oracle would have had a crack at Procore and, if they bought that, then ACX would have been up against a competitor with a development budget in the billions.

There is only one chance to dominate this market without spending a ludicrous amount of money to try and replicate what ACX has - I hope others recognise this and a bidding war takes this past its previous high so those few who bought in the $8's and are still holding get a profit too. The best price is always at an auction and Oracle are currently playing the part of the buyer's advocate with an attempt at a knock-out bid! I just hope 2-3 others decide to put their Christmas plans on hold and get stuck in!

Good luck to all!
MO

As always, DYOR!!

Expand

Yeh, no point selling now imo, not only will March push some of my buys over the 12 mths but further bids may come and if not then 7.80 is 7.80.

Best Wishes Everyone, have a happy and safe Christmas.

ACX Price at posting: $7.63 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

ME1

Banshee's historic trenches prove rich in antimony and gold for GDM

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 46, 2024

LYN

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

EDE

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

AUN

Cyclone signs MOU with Vale for development of Iron Bear play

AN1

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

There are more pages in this discussion • 34 more messages in this thread...

First 7 Last

Add ACX (ASX) to my watchlist

Yeh, no point selling now imo, not only will March push some of...

Top Stories

Banshee's historic trenches prove rich in antimony and gold for GDM

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 46, 2024

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Cyclone signs MOU with Vale for development of Iron Bear play

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing